Dr. Ken Spielvogel

Number three, if really you wanna look at it, Alzheimer's disease, dementia, and the complications thereof of that.

And number four, metabolic diseases, which are what?

Which are diabetes.

you know, is the big one.

Then we get into women.

More women die of hip fracture osteoporosis than they do of breast cancer in this country.

And that's a whole other podcast to talk about why that is and the epidemic of that and I would love to go through that.

So now we have a drug that you take once a week, okay, that has been shown to, I'm gonna say it in really simple terms that people understand.

It goes to your arteries and that lining of the arteries, which is so delicate that you wanna keep nice and smooth and the effects of smoking, environmental exposures that create these little dents and cracks in it that allow cholesterol to hang onto there and form a clot, a plug that then causes a heart attack.

So you have a medication out there that's gonna keep them smooth.

that's gonna keep them from spasming, that's gonna lower your blood pressure.

That's what the GLP-1s do.

On top of, it's gonna lower weight so that your heart isn't pumping and working as hard.

So there goes number one.

And your blood pressure isn't.

Right, and your blood pressure's gonna come down.

Number two, we're gonna go to cancer.

For women, obesity lends itself to fat cells that produce estrogen that increase your risk of potentially, you know,

maybe a promoter of breast cancer.

I'm really hesitant to say that, but there's probably a role in there.